Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
28 sept. 2023 08h00 HE
|
Quris Technologies
Merck KGaA and Quris-AI Expand Collaboration After a Successful Preclinical Study Assessed the Quris-AI BioAI Drug Safety Platform
Global Oxycodone Hydrochloride Market Size Scaling New Heights With $578.94 Million Projection by 2030, Showing a 4.66% CAGR
19 août 2023 19h00 HE
|
Zion Market Research
New York, NY, Aug. 19, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Oxycodone Hydrochloride Market By Type (Controlled-Release And Immediate-Release), By...
Quris-AI Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
02 mars 2023 07h00 HE
|
Quris Technologies
BOSTON and TEL-AVIV, Israel, March 02, 2023 (GLOBE NEWSWIRE) -- Quris-AI, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023. This year’s...
Quris Earns Additional Seed Investment Led by SoftBank Vision Fund 2
20 déc. 2022 08h00 HE
|
Quris Technologies
BOSTON and TEL-AVIV, Israel, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has secured an additional $9...
Deepfake Technology in Drug Design
20 oct. 2022 12h00 HE
|
InSilico Medicine
New York, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage artificial intelligence (AI)-driven drug discovery company, is utilizing the same deepfake technology used to create...
Walden Biosciences Appoints Peter Guest Linde, M.D. as Chief Medical Officer
11 oct. 2022 07h00 HE
|
Walden Biosciences, Inc.
CAMBRIDGE, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today...
Walden Biosciences Announces Research Collaboration with University of Michigan
05 juil. 2022 09h00 HE
|
Walden Biosciences, Inc.
CAMBRIDGE, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today...
Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Clinical Safety Prediction
10 févr. 2022 00h00 HE
|
Quris Technologies
BOSTON and TEL-AVIV, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has signed an agreement with...
Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services
11 oct. 2021 07h45 HE
|
Pace Analytical
MINNEAPOLIS, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Pace Analytical Life Sciences®, LLC, a subsidiary of Pace Analytical® Services, LLC, a full-service contract development and manufacturing organization...
Altasciences and Amador Bioscience Announce Strategic Collaboration
17 mars 2020 09h17 HE
|
Altasciences Company Inc.
LAVAL, Quebec, March 17, 2020 (GLOBE NEWSWIRE) -- Altasciences, a CRO in the U.S. and Canada specializing in a flexible, innovative approach to comprehensive early stage drug development, announced...